Brille Brian J 4
4 · Caris Life Sciences, Inc. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
Caris Life Sciences (CAI) Vice Chairman Brian J. Brille Receives RSU Award
What Happened
Brian J. Brille, Vice Chairman and Executive Vice President of Caris Life Sciences (CAI), received an award of 83,162 restricted stock units (RSUs) on 2026-03-06. The award is reported as an acquisition at $0.00 (typical for RSU grants); the RSUs will vest according to the applicable grant agreement (see footnote F1). This is a compensation grant (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-03-06; Form 4 filed: 2026-03-10 (filed timely).
- Transaction type/code: Award/Grant (A).
- Shares/units granted: 83,162 RSUs; reported acquisition price: $0.00.
- Vesting: RSUs vest in accordance with the applicable grant agreement (F1).
- Ownership notes: Reporting person disclaims beneficial ownership except for pecuniary interest (F2); shares are held via a family trust consolidating prior trusts (F3).
- Shares owned after transaction: Not specified in the filing.
Context
RSUs are a common form of executive compensation that convert to shares if and when they vest; they do not require an immediate cash purchase by the insider. Such grants are routine and reflect compensation rather than a direct market vote by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-06+83,162→ 244,290 total
- 500,000(indirect: By Trust)
Common Stock
[F2][F3]
Footnotes (3)
- [F1]Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
- [F2]The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F3]By a family trust, with shares previously held in multiple family trusts consolidated into a single trust.